$LRCX

Lam Research Stocks Fall 3.2% as Evercore Cuts Target Before Earnings

Lam Research (LRCX) shares fell 3.2% to $263.48 on October 20, ahead of earnings. Evercore ISI reduced its price target to $315 from $355, maintaining an Outperform rating. The company reported $1.457B in operating cash flow for Q2, with receivables growing 29.2% sequentially, outpacing revenue growth of 15.1%.

Original reporting
Published Oct 20, 2026, 8:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 8:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Lam Research Stocks Fall 3.2% as Evercore Cuts Target Before Earnings — source image
Decision brief

The 30-second read

$LRCXBearishMed
01

Why it matters

The target cut reflects concerns about cash conversion and receivables growth, potentially prompting short‑term sell‑offs.

02

Market read

Analyst target revisions are a key driver of short‑term price moves, especially for high‑visibility semiconductor equipment makers.

03

What to watch

Recent cash flow strength and receivables trends may support a higher valuation despite the target reduction.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Lam Research is a leading supplier of wafer fabrication equipment; its stock often reacts sharply to analyst outlooks before earnings.

Company-level read

Ticker impact

$LRCXBearishMedium confidence
Context

Evercore ISI lowered its price target for Lam Research to $315 from $355, and the stock fell about 3.2% ahead of earnings.

Expected impact

downward pressure as investors price in the lower target

Evidence & confidence

Analyst target reductions often precede short‑term price declines, especially when the stock is already down on earnings concerns.

Market effects

The downgrade may weigh on broader semiconductor equipment sector sentiment ahead of earnings season.

U.S. tech stocks could see modest pullback as investors reassess valuation multiples.

Limited; impact confined to investors tracking chip‑making equipment makers.

Counterpoint

If earnings beat expectations, the target cut could be an overreaction and present a buying opportunity.

Key entities

  • Evercore ISI

    Equity research firm that lowered Lam Research's price target.

Related articles

$TXNHighAI 8/10

Texas Instruments and Lam Research Report Earnings: AI Equipment Boom Meets Analog Rebound

Texas Instruments (TXN) and Lam Research (LRCX) report earnings on October 21. TXN, up 59.2% YTD, must show sustained industrial and auto demand. LRCX, down 12.1% in a week but up 59.0% YTD, needs to confirm AI-driven growth. TXN guided Q4 revenue to $5.65B-$6.15B and EPS to $2.23-$2.57. LRCX guided Q3 revenue to $8.1B±$400M and EPS to $2.15±$0.15, with 2026 wafer fab equipment spending forecast at low $150B.

$LRCXHigh

Deutsche Bank Makes Major Call on Lam Research Stock

Deutsche Bank raised its price target on Lam Research (LRCX) to $375 from $320, maintaining a Buy rating. The bank expects a strong quarter and highlights Lam's positioning in memory and foundry capacity expansion. Consensus estimates for Q1 2027 are $2.28 EPS on $8.13B revenue, up from $1.26 EPS on $5.32B last year. Deutsche notes that investors will focus on gross margins, market share, and supply-chain execution.